International Validation of a Delirium Prediction Model for ICU Patients
NCT ID: NCT01249755
Last Updated: 2012-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2011-11-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
NCT02518646
Evaluation of Delirium Prevention in Critically Ill Patients
NCT01187667
DeltaScan Validation Study for the Assessment of Delirium in the ICU and on Wards
NCT03966274
Predicting Delirium by Attentional Dysfunction
NCT03988179
Nursing Assistant Intervention to Prevent Delirium in Nursing Homes
NCT02994979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
delirious patients
The cohort is divided in delirious and non-delirious patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* sustained comatose during complete ICU stay
* admission duration less than twelve hours;
* serious auditory or visual disorders
* unable to understand the language of the included centre
* severely mentally disabled
* serious receptive aphasia
* or if there are missing or incomplete delirium screenings during admission to the ICU
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark van den Boogaard
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark van den Boogaard, MSc
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20110901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.